Introduction promoter as a paradigm, we find that p53 adjusts TGF-␤-induced transcription by interacting directly with a Members of the TGF-␤ growth factor family are promicognate binding site on promoter DNA. However, differnent signals regulating cellular fates in a variety of physient from other Smad partners, this p53 binding element ological contexts, from embryonic development to adult is located in a separate position from the Activin/TGF-␤ tissue homeostasis (Massagué , 2000) . The loss of this responsive element. We argue that these findings unveil control leads to aberrant cell behaviors contributing to a convergence of the p53 and the Smad signaling netthe development of cancer and inborn defects (Wakeworks to regulate development and tissue homeostasis. unbiased functional screen for genes whose expression nally modified p53 isoform has not been described in human or frog cells that express regular p53 (p53R) promoted the differentiation of embryonic cells into endoderm and mesoderm, as this is the hallmark of TGF-␤ (Wolkowicz et al., 1995) . Xenopus and mammalian p53 proteins share similar functional properties and regulasignaling in early vertebrate embryos (Whitman, 2001 ). We generated a mouse gastrula (embryonic day [E]6.5) tory mechanisms (Cox et al., 1994) . To assay for functional conservation, we compared the ability of mouse cDNA library constructed in an RNA expression plasmid. Synthetic mRNA was prepared from pools of 100 bactep53AS, human p53R, and Xenopus p53 (Xp53) to induce mesoendoderm differentiation in animal cap assays. rial colonies and injected into the animal hemisphere of 2-cell Xenopus embryos. At the blastula stage, the Figure 1C shows that the inducing activities of mp53AS and Xp53 are similar. hp53R can also stimulate expresectoderm was explanted and cultivated until siblings reached the gastrula stage. The injected animal caps sion of the same marker genes but at 5-to 10-fold lower efficiency than mp53AS, perhaps revealing a partial inwere then assayed by RT-PCR to identify pools able to activate the expression of Mixer (endoderm) and Xbra hibitory role for p53 C terminus in these activation processes. Of note, injection of higher doses (above 400 (mesoderm). Of five positive pools, two of the active cDNAs isolated after sib selection corresponded to pg for all mRNAs) was detrimental for survival (data not shown). Smad2 (Baker and Harland, 1996) and, unexpectedly, three corresponded to p53AS, a natural variant of p53 p53 may stimulate TGF-␤ gene responses acting in partnership with endogenous Smads or, alternatively, generated by alternative splicing at the C terminus (Wolkowicz et al., 1995). p53AS shares with commonly operating in an independent pathway. To discriminate between these two possibilities, we tested whether a spliced p53 (p53R) the N-terminal transactivation domain, the central DNA binding and oligomerization doblockade of Smad function had an effect on p53-mediated gene expression. As shown in Figure 1D , coinjecmains, but lacks the most C-terminal 26 amino acids of p53R.
tion of p53AS and dominant-negative Smad2 (Candia et al., 1997) mRNAs downregulated all the TGF-␤-like A wealth of data indicates that the TGF-␤ and p53 signaling networks operate independently as powerful inductions triggered by p53AS. We conclude that expression of p53 activates the transcription of TGF-␤ tumor suppressors in mammalian cells; yet, the cloning of a p53 isoform in a TGF-␤ screen unveiled the possibiltarget genes in a Smad-dependent fashion.
To explore the possibility that p53 and Smad may ity of a previously unrecognized partnership between these two types of molecules. We initially addressed jointly control the TGF-␤ output, we tested whether raising the levels of p53 may correspond to an enhanced this issue by characterizing the p53AS effects in more detail. Different doses of p53AS mRNA were injected in responsiveness to TGF-␤. Figure 1E shows that in animal caps explants, coinjection of suboptimal levels of activin the animal pole of each blastomere at the 2-cell stage and tested for the induction of several tissue-specific and p53AS mRNAs cooperated in the induction of endodermal and mesodermal markers, whereas each compomarkers in animal cap cells explanted from these embryos ( Figure 1A) . At lower doses of injected mRNA, nent alone was weak or inactive. In contrast, the BMP4 target Vent-1 was neither induced by p53AS alone nor p53AS induced first mesodermal (Xbra, Eomes) and then mesendodermal (VegT, Mix.2) genes; at a higher conin combination with BMP4 (see Supplemental Figure  S1A online at http://www.cell.com/cgi/content/full/113/ centration, mainly endodermal markers were turned on (Sox17␤, Mixer, Xnr6) ( Figure 1A, lanes 1-5) . This pattern 3/301/DC1). We further tested whether p53-mediated effects are of gene expression is typical of the ectopic activation of TGF-␤/Activin/Nodal/Smad2 signaling in animal caps direct by assaying the biological activities of p53 and Smad2 in the presence of cycloheximide, a protein syn-( Figure 1A , lanes 6 and 7) (Harland and Gerhart, 1997). However, other genes activated by Activin/Smad2 such thesis inhibitor. Transcription of Xbra, Mix.2, and Eomes is initiated as immediate response to Activin/Smad2 as goosecoid, XWnt8, and Xnr-1 were not induced in p53AS-injected cells ( Figure 1A, bottom) . This suggests stimulation in Xenopus animal caps (Harland and Gerhart, 1997) and, as shown in Supplemental Figure S1B , that p53AS specifically activates a subset of TGF-␤ target genes.
p53 directly promotes transcription of the same genes in the absence of de novo protein synthesis. In keeping We tested the biological activity of p53 mRNA in the context of the whole embryo. When microinjected into with this notion, injection of p53 alleles bearing inactivating mutations in the DNA binding (R273H) or transactivaa single ventral blastomere at the 4-cell stage, p53AS mRNA induced the formation of ectopic trunk-tail struction domain (22-23) failed to induce any mesoendodermal marker ( Figure 1F ). This suggests that p53 relies tures (n ϭ 155, 77%), phenocopying the biological effects triggered by low doses of Smad2 mRNA ( Figure 1B) entirely on its properties as sequence-specific transcription factor in these inductive events. (Baker and Harland, 1996) . Histological analysis showed that these secondary structures contained muscle, neup53 is biochemically a latent transcriptional regulator that becomes active in response to a variety of stimuli ral tissue, and in several cases an ectopic gut, but all lacked notochord (data not shown). (Vogelstein et al., 2000) . Little is known on the activation status of Xp53 in early embryos. This can be visualized We conclude from these experiments that ectopic expression of p53 stimulates multiple gene responses by monitoring p53-dependent transcription. To this end, we injected at the 1-cell stage a luciferase reporter for and long-term phenotypic effects typically mediated by activation of the TGF-␤ signaling cascade in embryonic p53 signaling whose transcription is driven by multimerized p53 binding elements (PG13) (Kern et al., 1992) . We cells (Harland and Gerhart, 1997) .
Alternative spliced p53AS represents up to 30% of compared PG13 transcription with MG13, in which the p53 binding elements are disrupted. Intriguingly, we total p53 in rodent cells but, curiously, a similar C termi- We next asked whether p53 function was also resayed molecularly using probes for Chordin and XmyoD, whose expression at the neurula stage marks axial quired in the whole embryo. Several findings have demonstrated that Nodals and Derriere, a group of TGFmesoderm and prospective skeletal muscle, respectively. As shown in Figure the BrdU incorporation after siRNA-mediated ablation mation, whereas TIEG is thought to be important in TGFof p53, indicating that p53 knockdown is sufficient to ␤-mediated apoptosis.
overcome the growth arrest imposed by TGF-␤ sigWe analyzed the relevance of p53 in the activation of naling. these TGF-␤ targets. For this purpose, we reduced the Lack of sensitivity to TGF-␤ growth-suppressing efendogenous levels of p53 using the small interfering fects is a landmark of most cancers. Given that a high RNA (siRNA) technique in the HepG2 model system (Fig- proportion of human cancers carry mutations in p53, ure 3A), as this hepatoma cell line is highly TGF-␤/Activin our data at least suggest that inactivation of p53 may responsive and expresses wild-type p53, but not p63 be one of the possible mechanisms for the selective or p73. Figure 3B shows RT-PCR analyses in which all loss of TGF-␤ tumor-suppressing effects in cancer cells. the markers were clearly upregulated in HepG2 cells as We explored this hypothesis trying to restore the antian early response to Activin treatment. In the presence proliferative effects of TGF-␤ in cancer cell lines lacking of anti-p53 siRNA, these inductions were reduced for p53. SAOS-2 is a p53 null osteosarcoma cell line, not p21 WAF1 , MMP2, and PAI-1. Notably, induction of TIEG expressing p63 or p73, that is insensitive to growth arwas p53 independent, implicating that p53 knockdown rest mediated by TGF-␤ treatment or overexpressed has no effect, per se, on the overall TGF-␤ responSmad2 ( Figure 3E, Figure 3C , the relevant for some biological responses to TGF-␤ in normal cell types. One complicating issue in the interpretaelevation of p21 WAF1 as response to Activin requires p53 Figure 4E ). We conclude that p53 is a significant player in the antiprolifwere seeded at low density and treated with different doses of TGF-␤1; the distribution of the cell population erative effects mediated by TGF-␤ in embryonic fibroblasts. in the G1 and S phases of the cell cycle was analyzed by flow cytometry after TGF-␤1 treatment and the perWe next aimed to extend these findings to an additional experimental system reflecting a role of TGF-␤ in centage of cells in active DNA synthesis was assayed by BrdU incorporation. As shown in Figures 4A-4D, wild- vivo. TGF-␤ signaling has been shown to restrain the proliferative potential of hematopoietic progenitors type MEFs were efficiently growth arrested by TGF-␤1, ARE (Ϫ215, Ϫ166) ( Figure 6A ). To test whether p53BE can recruit endogenous p53, we carried out DNA affinity Ablation of p53 by siRNA in HepG2 cells reduced inducibility by TGF-␤, but had no effect on the unstimuprecipitation experiments (DNAP) with a p53BE doublestranded biotinylated oligonucleotide using nuclear exlated promoter basal state ( Figure 5B) . Similar results were obtained with the promoter of PAI-1, another gene tracts from control and Activin-treated HepG2 cells. Endogenous p53 bound to p53BE, but not to a mutant under dual control of p53 and TGF-␤ in mammalian cells (see Supplemental Figure S4 online at http://www.cell. p53BE probe, irrespectively from Activin stimulation ( Figure 6B ). In gel shift assays, recombinant purified com/cgi/content/full/113/3/301/DC1). We conclude from these experiments that p53 enhances Smad-GST-p53AS, p53R, and p73 specifically bound the Mix.2 p53BE (Figure 6C ), indicating the direct contact of p53 dependent transcription in vivo.
Mechanistically, p53 may act at any level upstream with its consensus site. To investigate whether the interaction of p53 on its of the Smad pathway (for example, inhibiting Smad degradation); if so, its partnership with TGF-␤ should be target DNA is instrumental for cooperation with TGF-␤ in Mix.2 transactivation, we generated a mutant luciferase observed not only on the natural promoter fragments used so far, but also on synthetic reporters of Smad reporter construct in which the p53 site was deleted (⌬p53). In HepG2 cells, deletion of p53BE completely activity. Importantly, as shown in Figure 5C , we found no transcriptional cooperation between TGF-␤ and blocked the TGF-␤/p53 transcriptional synergism (Figure 6D ). p53AS on ARE3-lux, a synthetic sensor of Activin/TGF-␤ signaling derived from multimerization of the activin reWe then examined the relative importance of the Activin-and p53 responsive elements in the transcriptional sponsive element (ARE) of the Mix.2 promoter (Huang  et al., 1995) . We conclude from these experiments that response to Activin in animal cap assays. Two constructs were generated bearing point mutations in the the partnership between TGF-␤ signaling and p53 is specific and must operate through separate enhancer p53 consensus (M-p53BE) and in the FAST-1 binding site (M-ARE). In animal cap assays, M-p53BE was actielements; thus, p53 appears as an independent input in TGF-␤-mediated transcription, rather that a general vated less efficiently than wild-type Mix.2 at all concentrations of activin mRNA tested ( Figure 6E ). As expected component of the activated Smad complex.
As p53 regulates TGF-␤ gene responses, we verified M-ARE showed no activity (Huang et al., 1995) . Thus, binding of endogenous Xp53 to its cognate site is rewhether the converse was true, that is whether p53 may lysates from 293T cells transfected with Smad2 and To determine whether the interaction of p53 and Smad2/3 occurred with physiological levels of these Smad4 were incubated with immobilized GST, GST-p53, or GST-p73. As shown in Figure 7A , Smad2, but not proteins, we precipitated endogenous p53 from HepG2 cells either untreated or stimulated with Activin for 1 hr. Smad4, bound to immobilized p53 and p73 in a TGF-␤ manner. The interaction between p53AS and Smad2 was To select for the pool of active cellular p53 able to bind to DNA, we carried out DNA affinity precipitation using confirmed in vivo with coimmunoprecipitation experiments with overexpressed proteins ( Figure 7B At difference with mammals, we find little potential p53 activity is required on DNA for full TGF-␤ transactifor redundancy in frog embryos, which express only p53 vation. Of note, we find a correlation between other during early development (Supplemental Figure S6G) . genes that in our assays are under joined control of p53 Indeed, p73 is not found in the lower vertebrates, and and Smad, and the presence of a functional p53 binding p63 is only expressed at later stages during organogeneelement in their promoters. This is the case for p21 
